Nvidia's stock (NASDAQ:NVDA) is trading 1.14% higher in the pre-market, given a boost following Truist Securities' decision to increase its price target, even as the broader artificial intelligence (AI) sector faces turbulent

Amazon's stock demonstrated resilience this morning, moving higher in pre-market trading despite speculation linking the tech giant to a terminated funding agreement with Fermi America (FRMI) for a Texas data center project.

Oracle's stock price (NYSE:ORCL) has given bulls something to cheer this morning, bouncing off the $180 level in pre-market trading following the announcement of a finalized agreement regarding TikTok's U.S. operations. 

CoreWeave's stock (NASDAQ: CRWV) has bounced off the recent drop, with a 5.10% gain in pre-market trading today adding to a 4.85% increase during Thursday's session. After having fallen 28.8% from the week following December 9th, support has stepp

The FTSE 100 was flat on Friday as investors digested weaker-than-expected UK retail sales data and company-specific developments. Elsewhere in Europe, the DAX rose 0.2% a

Rentokil Initial (LON: RTO) shares could have further upside after Bank of America upgraded the pest control group to Buy from Neutral, citing an “untapped” growth opportunity and recent share price underperformance.

Whitbread shares jumped 6.3% on Thursday after activist investor Corvex Management disclosed a 6.05% economic interest in the Premier Inn owner and called for a strategic review of the group’s direction and capital allocation

Vp plc (VP.), a specialist equipment rental group, has announced Alice Woodwark as its new Chief Executive Officer, effective February 1, 2026. This appointment follows a

Applied Nutrition plc (APN) shares are up around 1.2% on Friday morning after the company announced a three-year out-licensing agreement with Morrisons, a major UK supermarket chain.

Capita plc (CPI.L) has announced a significant four-year contract renewal with a major European telecommunications provider, valued at £62 million. The deal, commencing in January 2026, underscores Capita's strategic shift to

The Financial Conduct Authority (FCA) has launched a formal investigation into WH Smith following the previously announced accounting errors woes. This development follows

FedEx stock (NYSE:FDX) is trading at $283.73 into earnings, up 0.5% on the day. The stock has rallied more than 40% off the lows, and shows signs of a potential breakout, having crossed through the $280 level.

Nike's stock price (NYSE:NKE) is up 0.37% at $66 today, with earnings casting a shadow after market close. The street is bracing for earnings, with the expected EPS of $0.3

The FTSE 100 index closed 0.65% higher at 9,837.77 today, buoyed by the Bank of England's (BoE) decision to cut interest rates. The central bank's move, aimed at stim

Joby Aviation's stock price (NYSE: JOBY) is 2.65% higher this morning following the announcement of a strategic partnership with Metropolis Technologies. The collaboration aims to develop 25 vertiport sites across the United

Lam Research Corporation (NASDAQ: LRCX) is experiencing upward momentum, with the stock trading 2.5% higher in pre-market activity following an analyst upgrade. This positive movement reflects growing confidence in the semiconductor equipment manu

Palo Alto Networks stock (NASDAQ:PANW) is 0.53% higher during the pre-market,  as an updated analysis from Morgan Stanley indicates a preference for PANW over its cybersecurity peer, CrowdStrike (CRWD).

The Walt Disney Company's stock (NYSE:DIS) has been given a vote of confidence this morning as Wells Fargo elevates the stock to its top media pick, a move that sees Spotify (SPOT) relinquish the position. This endorsement re

Micron Technology's stock (NASDAQ:MU) experienced a significant surge following a robust earnings report and a wave of analyst upgrades. The positive momentum stems from heightened demand for memory chips, particularly those utilized in artificial in

Eli Lilly & Co (LLY) is experiencing positive market sentiment following the release of encouraging topline results from its ATTAIN-MAINTAIN trial, coupled with news of the FDA potentially expediting the review process fo